# AstraDose
Anticancer drug dose adjuster for patients with multiple organ dysfunction syndrome

<strong>Table 1.</strong> Adaptation of anticancer drugs in patients with renal or hepatic impairment
<table>
<tbody>
<tr>
<td width="29">
<p><strong>N</strong></p>
</td>
<td width="170">
<p><strong>Medicines</strong></p>
</td>
<td width="179">
<p><strong>Renal impairment</strong></p>
</td>
<td width="223">
<p><strong>Hepatic impairment</strong></p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>01</strong></p>
</td>
<td width="170">
<p>ACETATE D&rsquo;ABIRATERONE</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>02</strong></p>
</td>
<td width="170">
<p>ACIDE ZOLEDRONIQUE</p>
</td>
<td width="179">
<p>CrCl &lt; 35 mL/min: CI</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>03</strong></p>
</td>
<td width="170">
<p>AFATINIB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>04</strong></p>
</td>
<td width="170">
<p>AFLIBERCEPT</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>05</strong></p>
</td>
<td width="170">
<p>ALEMTUZUMAB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>06</strong></p>
</td>
<td width="170">
<p>AMASACRINE</p>
</td>
<td width="179">
<p>CrCl &lt; 30 mL/min: 70%</p>
</td>
<td width="223">
<p>&bull; Bili &gt; 20mg/l: 60 -70%</p>
<p>&bull; &gt; 36mg/l: 50 % or not recommended</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>07</strong></p>
</td>
<td width="170">
<p>ASPARAGINASE</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>&gt; 36mg/l: CI</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>08</strong></p>
</td>
<td width="170">
<p>AXITINIB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>09</strong></p>
</td>
<td width="170">
<p>AZACITIDINE</p>
</td>
<td width="179">
<p>Creatininemie &ge; 14-26 mg/L for men and 10-24 mg/L for women: 50%</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>10</strong></p>
</td>
<td width="170">
<p>BENDAMUSTINE</p>
</td>
<td width="179">
<p>CrCl &lt; 40 mL/min: CI</p>
</td>
<td width="223">
<p>&bull; Bili &lt; 12 mg/l: NA</p>
<p>&bull; Bili 12mg/l &ndash; 30mg/l: 70%</p>
<p>&bull; Bili &gt; 30mg/l : CI</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>11</strong></p>
</td>
<td width="170">
<p>BEVACIZUMAB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>12</strong></p>
</td>
<td width="170">
<p>BLEOMYCINE</p>
</td>
<td width="179">
<p>&bull; CrCl &lt; 50 mL/min: 70%</p>
<p>&bull; CrCl &lt; 40 mL/min: 60%</p>
<p>&bull; CrCl &lt; 30 mL/min: 55%</p>
<p>&bull; CrCl &lt; 20 mL/min: 45%</p>
<p>&bull; CrCl &lt; 10 mL/min: 40%</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>13</strong></p>
</td>
<td width="170">
<p>BLINATUMOMAB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>14</strong></p>
</td>
<td width="170">
<p>BORTEZOMIB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>&bull; Bili &le;18mg/l: NA</p>
<p>&bull; Bili &gt;18mg/l: 50%</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>15</strong></p>
</td>
<td width="170">
<p>BRENTUXIMAB</p>
</td>
<td width="179">
<p>&bull; CrCl &lt; 30 mL/min: 1,2 mg/k</p>
<p>&bull; CrCl&nbsp; &lt; 15 mL/min: CI</p>
</td>
<td width="223">
<p>&bull; Bili: 12- 18mg/l: 66%</p>
<p>&bull; Bili &gt;18- 36mg/L: CI</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>16</strong></p>
</td>
<td width="170">
<p>CABAZITAXEL</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>&bull; Bili&nbsp;: 12- 18mg/l&nbsp;or ASAT H&gt;40UI/L F &gt;38UI/L: 80%</p>
<p>&bull; Bili 18- 36mg/L:60%</p>
<p>&bull; &gt; 36mg/l: CI</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>17</strong></p>
</td>
<td width="170">
<p>CAPECITABINE</p>
</td>
<td width="179">
<p>&bull; CrCl &lt; 50 mL/min: 75 %</p>
<p>&bull; CrCl &lt; 30 mL/min: CI</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>18</strong></p>
</td>
<td width="170">
<p>CARBOPLATINE</p>
</td>
<td width="179">
<p>CALVERT</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>19</strong></p>
</td>
<td width="170">
<p>CARFILOZOMIB</p>
</td>
<td width="179">
<p>CrCl &lt; 15 mL/min: 50%</p>
</td>
<td width="223">
<p>&bull; Bili 12mg/l &ndash; 36mg/l: 75%</p>
<p>&bull; &gt; 36mg/l: CI</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>20</strong></p>
</td>
<td width="170">
<p>CETUXIMAB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>21</strong></p>
</td>
<td width="170">
<p>CHLORAMBUCIL</p>
</td>
<td width="179">
<p>&bull; CrCl &lt; 60 mL/min: 1,5 to 9mg/day</p>
<p>&bull; CrCl &lt; 15 mL/min: 1 to 6 mg/day</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>22</strong></p>
</td>
<td width="170">
<p>CISPLATINE</p>
</td>
<td width="179">
<p>&bull; CrCl &lt; 60 mL/min: 50 %</p>
<p>&bull; CrCl &lt; 45 mL/min: 25 %</p>
<p>&bull; CrCl &le; 30 mL/min: CI</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>23</strong></p>
</td>
<td width="170">
<p>CLADRIBINE</p>
</td>
<td width="179">
<p>&bull; CrCl &lt; 50 mL/min: 75%</p>
<p>&bull; CrCl &lt; 10 mL/min: 50%</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>24</strong></p>
</td>
<td width="170">
<p>CRISANTASPASE</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>BILI &gt;12mg/l: CI</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>25</strong></p>
</td>
<td width="170">
<p>CRIZOTINIB</p>
</td>
<td width="179">
<p>CrCl &le; 30 mL/min: 250 mg daily (no dialysis required), the dosage may be increased to 200 mg twice daily based on individual safety and tolerance.</p>
</td>
<td width="223">
<p>BILI &gt;12mg/l: CI</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>26</strong></p>
</td>
<td width="170">
<p>CYCLOPHOSPHAMIDE</p>
</td>
<td width="179">
<p>CrCl &lt; 10 mL/min: 50 %</p>
</td>
<td width="223">
<p>&bull; T.Bil &gt; 31&ndash;50 mg/L or AST &gt; 180 IU/L: 75%</p>
<p>&bull; T.Bil &gt; 50 mg/L: CI</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>27</strong></p>
</td>
<td width="170">
<p>CYTARABINE</p>
</td>
<td width="179">
<p>&bull; CrCl &lt; 60 mL/min: 50%</p>
<p>&bull; CrCl &lt; 40 mL/min: 25 %</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>28</strong></p>
</td>
<td width="170">
<p>DACARBAZINE</p>
</td>
<td width="179">
<p>&bull; CrCl &lt; 60 mL/min: 75%</p>
<p>&bull; CrCl &lt; 30 mL/min: 50%</p>
<p>&bull; CrCl &lt; 10 mL/min: CI</p>
</td>
<td width="223">
<p>T.Bil &gt; 36mg/l: CI</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>29</strong></p>
</td>
<td width="170">
<p>DACTINOMYCINE</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>30</strong></p>
</td>
<td width="170">
<p>DASATINIB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>31</strong></p>
</td>
<td width="170">
<p>DAUNORUBICINE</p>
</td>
<td width="179">
<p>Creatininemie &gt; 30 mg/L: 50%</p>
</td>
<td width="223">
<p>&bull; T.Bil 15&ndash;30 mg/L or AST 60&ndash;180 IU/L: 75%</p>
<p>&bull; T.Bil &gt; 31&ndash;50 mg/L or AST &gt; 180 IU/L: 50%</p>
<p>&bull; T.Bil &gt; 50 mg/L: CI</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>32</strong></p>
</td>
<td width="170">
<p>DENOSUMAB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>33</strong></p>
</td>
<td width="170">
<p>DOXORUBICINE</p>
</td>
<td width="179">
<p>CrCl &lt; 10 mL/min: 75%</p>
</td>
<td width="223">
<p>&bull; T.Bil 15&ndash;30 mg/L or AST 60&ndash;180 IU/L: 50%</p>
<p>&bull; T.Bil &gt; 31&ndash;50 mg/L or AST &gt; 180 IU/L: 25%</p>
<p>&bull; T.Bil &gt; 50 mg/L: CI</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>34</strong></p>
</td>
<td width="170">
<p>DOCETAXEL</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>&bull; ASAT H&gt;60UI/L F &gt;48UI/L or PAL H&gt;325 UI/L F &gt;262,5UI/L: 75%</p>
<p>&bull; Bili &gt;12mg/l and/or [asat&nbsp; H&gt; 140 UI/L F &gt;112 UI/L with PAL H &gt;780UI/L&nbsp; F&gt; 630UI/L]: CI</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>35</strong></p>
</td>
<td width="170">
<p>ENZALUTAMIDE</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>36</strong></p>
</td>
<td width="170">
<p>EPIRUBICINE</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>&bull; Bili 12-30mg/l or asat (H 80UI/L F 64UI/L &ndash; H160UI/L&nbsp; F128UI/L): 50%</p>
<p>&bull; Bili &gt; 30mg/l or asat H160UI/L&nbsp; F128UI/L: 25%</p>
<p>&bull; Bili&gt; 36mg/l: CI</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>37</strong></p>
</td>
<td width="170">
<p>ERIBULINE</p>
</td>
<td width="179">
<p>CrCl&nbsp; &lt; 50 mL/min: 80%</p>
</td>
<td width="223">
<p>BILI &gt;36mg/l: CI</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>38</strong></p>
</td>
<td width="170">
<p>ERLOTINIB</p>
</td>
<td width="179">
<p>CrCl &lt; 10 mL/min: CI</p>
</td>
<td width="223">
<p>&bull; AST H &ge; 120 UI/L&nbsp; F &ge;96UI/L or T.Bil 1&ndash;7 mg/L: &nbsp;50%</p>
<p>&bull; T.Bil &gt; 70 mg/L: CI</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>39</strong></p>
</td>
<td width="170">
<p>ETOPOSIDE</p>
</td>
<td width="179">
<p>&bull; CrCl &lt; 50 mL/min: 75%</p>
<p>&bull; CrCl &lt; 15 mL/min: CI</p>
</td>
<td width="223">
<p>&bull; T.Bil 15&ndash;30mg/L or AST 60&ndash;180 UI/L: 50%</p>
<p>&bull; T.Bil &ge; 30 mg/L or AST &gt; 180 UI/L: CI</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>40</strong></p>
</td>
<td width="170">
<p>EVEROLIMUS</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>41</strong></p>
</td>
<td width="170">
<p>FLUDARABINE</p>
</td>
<td width="179">
<p>&bull; CrCl &lt; 70 mL/min: 50%</p>
<p>&bull; CrCl &lt; 30 mL/min: CI</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>42</strong></p>
</td>
<td width="170">
<p>FLUOROURACILE</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>T.Bil &gt; 50 mg/L: CI</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>43</strong></p>
</td>
<td width="170">
<p>FULVESTRANT</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>44</strong></p>
</td>
<td width="170">
<p>GEFITINIB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>45</strong></p>
</td>
<td width="170">
<p>GEMCITABINE</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>&bull; Asat H &gt;40UI/L, F&gt;32UI/L: No adaptation</p>
<p>&bull; T.Bil&gt;12mg/L: 80%</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>46</strong></p>
</td>
<td width="170">
<p>HYDROXYCARBAMIDE</p>
</td>
<td width="179">
<p>&bull; CrCl &lt;&nbsp; 60 mL/min: 75%</p>
<p>&bull; CrCl &lt; 10 mL/min: 50%</p>
</td>
<td width="223">
<p>&bull; T.bili 15-50mg/L or Asat 60-180IU/L: 50%</p>
<p>&bull; T.bili &gt;50mg/l or Asat &gt; 180 UI&nbsp;/l: CI</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>47</strong></p>
</td>
<td width="170">
<p>IBRUTINIB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>48</strong></p>
</td>
<td width="170">
<p>IFOSFAMIDE</p>
</td>
<td width="179">
<p>&bull; CrCl &lt; 60 mL/min: 80%</p>
<p>&bull; CrCl &lt; 45 mL/min: 75%</p>
<p>&bull; CrCl &lt; 30 mL/min: 70%</p>
<p>&bull; CrCl &lt; 10 mL/min: CI</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>49</strong></p>
</td>
<td width="170">
<p>IMATINIB</p>
</td>
<td width="179">
<p>CrCl &lt; 60 mL/min: 400 mg</p>
</td>
<td width="223">
<p>T.Bil &gt;12mg/l: 400 mg</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>50</strong></p>
</td>
<td width="170">
<p>IRINOTECAN</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>&bull; Increased AST: No adaptation.</p>
<p>&bull; T.Bil 18mg/l &ndash;36 mg/l&nbsp; and ratio of AST to ALT &lt; 5 &times; ULN: 75%</p>
<p>&bull; T.Bil 37,2 mg/l &ndash;60mg/l and ratio of AST to ALT &lt; 5 &times; ULN: 40%</p>
<p>&bull; T.Bil &lt; 18 mg/l ratio of AST to ALT 5.1&ndash;20 &times; ULN: 75%</p>
<p>&bull; T.Bil 18mg/l &ndash;36 mg/l&nbsp; and ratio of AST to ALT 5.1&ndash;20 &times; ULN: 30%</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>51</strong></p>
</td>
<td width="170">
<p>IDARUBICINE</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>Bili &gt;36mg/l: CI</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>52</strong></p>
</td>
<td width="170">
<p>LANREOTIDE</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>53</strong></p>
</td>
<td width="170">
<p>LAPATINIB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>54</strong></p>
</td>
<td width="170">
<p>LENALIDOMIDE</p>
</td>
<td width="179">
<p>&bull; CrCl &lt;&nbsp; 60 mL/min: 10 mg every 24h&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; CrCl &lt; 30 mL/min (does not require dialysis): 15 mg every 48h</p>
<p>&bull; CrCl &lt; 30 mL/min (requires dialysis): 5 mg/day</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>55</strong></p>
</td>
<td width="170">
<p>LENOGRASTIM</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>56</strong></p>
</td>
<td width="170">
<p>MELPHALAN</p>
</td>
<td width="179">
<p>&bull; CrCl &lt; 60 mL/min: 85%</p>
<p>&bull; CrCl &lt; 45 mL/min: 75%</p>
<p>&bull; CrCl &lt; 30 mL/min: 70%</p>
<p>&bull; CrCl &lt; 10 mL/min: 50%</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>57</strong></p>
</td>
<td width="170">
<p>MERCAPTOPURINE</p>
</td>
<td width="179">
<p>&bull; CrCl &le; 50 mL/min: 50%</p>
<p>&bull; CrCl &lt; 20 mL/min: CI</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>58</strong></p>
</td>
<td width="170">
<p>METHOTRAXATE</p>
</td>
<td width="179">
<p>&bull; CrCl&nbsp; &lt; 50 mL/min: 50%</p>
<p>&bull; CrCl&nbsp; &lt; 15 mL/min: CI</p>
</td>
<td width="223">
<p>&bull; T.Bil 31&ndash;50 mg/L or AST &gt; 180 IU/L: 75%</p>
<p>&bull; T.Bil &gt; 50mg/L: CI</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>59</strong></p>
</td>
<td width="170">
<p>MITOMYCINE</p>
</td>
<td width="179">
<p>&bull; CrCl &lt; 60 mL/min: 75%</p>
<p>&bull; CrCl &lt; 30 mL/min: 50%</p>
<p>&bull; CrCl &lt; 10 mL/min: CI</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>60</strong></p>
</td>
<td width="170">
<p>NILOTINIB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>61</strong></p>
</td>
<td width="170">
<p>NIMOTUZUMAB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>62</strong></p>
</td>
<td width="170">
<p>NINTEDANIB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>63</strong></p>
</td>
<td width="170">
<p>NIVOLUMAB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>64</strong></p>
</td>
<td width="170">
<p>OXALIPLATINE</p>
</td>
<td width="179">
<p>CrCl &lt; 30 mL/min: CI</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>65</strong></p>
</td>
<td width="170">
<p>PACLITAXEL</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>&bull; Asat H&lt; 400UI/L&nbsp;F&lt; 320 UI/L and bili 19,2mg/l -24mg/l: 77%</p>
<p>&bull; Asat H&lt; 400UI/L&nbsp;F&lt; 320 UI/L and bili 24,12mg/l -60mg/l: 51%</p>
<p>&bull; Asat H&ge; 400UI/L&nbsp;F&ge; 320 UI/L and bili &gt; 60mg/l: not recommended&nbsp;&nbsp;or CI</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>66</strong></p>
</td>
<td width="170">
<p>PALBOCICLIB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>67</strong></p>
</td>
<td width="170">
<p>PANITUMUMAB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>68</strong></p>
</td>
<td width="170">
<p>PAZOPANIB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>69</strong></p>
</td>
<td width="170">
<p>PEMBROLIZUM</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>70</strong></p>
</td>
<td width="170">
<p>PEMETREXED</p>
</td>
<td width="179">
<p>CrCl &lt; 45 mL/min: CI</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>71</strong></p>
</td>
<td width="170">
<p>PERTUZUMAB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>72</strong></p>
</td>
<td width="170">
<p>PRALATREXATE</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>73</strong></p>
</td>
<td width="170">
<p>PROCARBAZINE</p>
</td>
<td width="179">
<p>CrCl &le; 30 mL/min: CI</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>74</strong></p>
</td>
<td width="170">
<p>RAMUCIRUMAB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>75</strong></p>
</td>
<td width="170">
<p>REGORAFENIB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>76</strong></p>
</td>
<td width="170">
<p>RITUXIMAB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>77</strong></p>
</td>
<td width="170">
<p>ROMIPLOSTIME</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>78</strong></p>
</td>
<td width="170">
<p>SORAFENIB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>79</strong></p>
</td>
<td width="170">
<p>SUNITINIB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>80</strong></p>
</td>
<td width="170">
<p>TARSTUZUMAB EMTANSINE</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>81</strong></p>
</td>
<td width="170">
<p>TEMOZOLOMIDE</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>82</strong></p>
</td>
<td width="170">
<p>THALIDOMIDE</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>83</strong></p>
</td>
<td width="170">
<p>TRASTUZUMAB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>84</strong></p>
</td>
<td width="170">
<p>TRETINOINE</p>
</td>
<td width="179">
<p>reduit a 25 mg/m&sup2;/jour</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>85</strong></p>
</td>
<td width="170">
<p>TRI OXYDE D'ARSENIC</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>86</strong></p>
</td>
<td width="170">
<p>VEMURAFENIB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>87</strong></p>
</td>
<td width="170">
<p>VINBLASTINE</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>&bull; T.Bil 15&ndash;30 mg/dL or ASAT 60&ndash;180 IU/L: 50%</p>
<p>&bull; T.Bil &gt; 31 mg/L or AST &gt; 180 IU/L: CI</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>88</strong></p>
</td>
<td width="170">
<p>VINCRISTINE</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>89</strong></p>
</td>
<td width="170">
<p>VINFLUNINE</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
</td>
<td width="179">
<p>&bull; CrCl&nbsp; &lt; 60 mL/min: 87,5%</p>
<p>&bull; 20 &lt; CrCl&nbsp; &lt; 40 mL/min: 75%</p>
</td>
<td width="223">
<p>&bull; Asat H&gt; 40UI/L F&gt; 32 UI/L and bili&gt;18mg/l: 78%</p>
<p>&bull; Asat H&gt; 40UI/L F&gt;32 UI/L and bili&gt;36mg/l: 62%</p>
<p>&bull; Asat H&ge; 100UI/L F&ge; 80 UI/L and bili &gt; 60mg/l: CI</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>90</strong></p>
</td>
<td width="170">
<p>VINORELBINE</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>&bull; T.Bil 25,2 mg/l &ndash;36mg/l: 50%</p>
<p>&bull; T.Bil &gt; 36mg/l: 25%</p>
</td>
</tr>
<tr>
<td width="29">
<p><strong>91</strong></p>
</td>
<td width="170">
<p>VISMODEGIB</p>
</td>
<td width="179">
<p>No adaptation</p>
</td>
<td width="223">
<p>No adaptation</p>
</td>
</tr>
</tbody>
</table>
